FreeNews Analysis Rejected Therapy Reveals Inconsistency of FDA Procedures for Drugs, Immunotherapies February 19, 2016Vol.42 No.07By Paul Goldberg
Conversation with The Cancer LetterFree Sigal: $75 Million Not Enough for FDA Reform February 12, 2016Vol.42 No.06
Free Obama’s $4.1 Trillion Budget Request Proposes Mandatory Funds for $1 Billion Cancer Moonshot February 12, 2016Vol.42 No.06By Matthew Bin Han Ong
Free White House Promises $1 Billion for Cancer Moonshot February 05, 2016Vol.42 No.05By Matthew Bin Han Ong
FreeIn Brief Ovarian Cancer National Alliance and Ovarian Cancer Research Fund merge January 29, 2016Vol.42 No.04
FreeIn Brief Tara Yates joins Wistar Institute as director of communications January 29, 2016Vol.42 No.04
Drugs & TargetsFree Zepatier approved for treatment of chronic hepatitis C January 29, 2016Vol.42 No.04
Drugs & TargetsFree Halaven approved for unresectable or metastatic liposarcoma January 29, 2016Vol.42 No.04
